(Press-News.org) In 2008 researchers from the University of Southern Denmark showed that the drug thioridazine, which has previously been used to treat schizophrenia, is also a powerful weapon against antibiotic-resistant bacteria such as staphylococci (Staphylococcus aureus).
Antibiotic-resistant bacteria is a huge problem all over the world: For example, 25 - 50 per cent of the inhabitants in southern Europe are resistant to staphylococci. In the Scandinavian countries it is less than 5 per cent, but also here the risk of resistance is on the rise.
So any effective anti-inflammatory candidate is important to investigate - even if the candidate is an antipsychotic that was originally developed to alleviate one of the hardest mental illnesses, schizophrenia.
Until now, scientists could only see that thioridazine works effectively and that it can kill staphylococcus bacteria in a flask in the laboratory, but now a new study reveals why and how thioridazine works. The research group, which includes professor Hans Jørn Kolmos, associate professor Birgitte H. Kallipolitis and other participants from the Department of Biochemistry and Molecular Biology and Institute of Clinical Medicine, University of Southern Denmark, publishes their findings in the journal PLOS ONE on May 17 2013.
The research team tested thioridazine on staphylococcal bacteria and discovered that thioridazine works by weakening the bacterial cell wall.
"When we treat the bacteria with antibiotics alone, nothing happens - the bacteria are not even affected. But when we add both thioridazine and antibiotics, something happens: thioridazine weakens the bacterial cell wall by removing glycine (an amino acid) from the cell wall. In the absence of glycine, the antibiotics can attack the weakened cell wall and kill staphylococcus bacteria", explains Janne Kudsk Klitgaard, visiting scholar at the Department of Biochemistry and Molecular Biology, University of Southern Denmark.
Thus, it is the interaction between thioridazine and antibiotic that works.
And now that researchers know that thioridazine works by weakening staphylococcal cell wall, they can concentrate on improving this ability.
"Now that we know how thioridazine works, we can develop drugs that target the resistant bacteria. And just as important: We can remove or inactivate the parts of thioridazine, which treats schizophrenia, so we end up with a brand new product that is no longer an antipsychotic, "explains Janne Kudsk Klitgaard.
According to her, we are now a little closer to a safe, non-psychopharmacological drug that can save people from potentially fatal infections that do not respond to antibiotics.
"This will no longer be an antipsychotic, when scientists are finished with this task," she says.
Together with her colleagues Klitgaard tested thioridazine on roundworms in the laboratory and have seen that they were cured of staphylococci in the gut. Next step will be testing on mice and pigs.
###
Contact: Janne Kudsk Klitgaard, tel + 45 6550 2376 Email: jkklitgaard@health.sdu.dk
Journal ref: Thioridazine induces major changes in global gene expression and cell wall composition in methicillin-resistant Staphylococcus aureus. USA300. PLOS ONE, May 17, 2013.
This press release was written by press officer Birgitte Svennevig, Faculty of Science, University of Southern Denmark.
Now we know why old scizophrenia medicine works on antibiotics-resistant bacteria
2013-05-18
ELSE PRESS RELEASES FROM THIS DATE:
Women's reproductive ability may be related to immune system status
2013-05-18
CHAMPAIGN, lll. — New research indicates that women's reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females.
The study appears in the American Journal of Human Biology.
An animal's energetic resources must be carefully allocated, said University of Illinois anthropology professor Kathryn Clancy, who led the new research. The body's first priority is maintenance, which includes tasks inherently related to survival, including immune function, she said. Any leftover energy is then dedicated ...
NASA sees Cyclone Mahasen hit Bangladesh
2013-05-18
NASA's Tropical Rainfall Measuring Mission satellite known as TRMM measured Cyclone Mahasen's rainfall rates from space as it made landfall on May 16. Mahasen has since dissipated over eastern India.
Tropical Cyclone Mahasen hit southern Bangladesh on May 16, causing the reported deaths of at least 13 people and the destruction of many homes. Mahasen brought heavy rains and tropical storm force winds when it came ashore, but the winds quickly weakened.
NASA's TRMM satellite had two very informative views as deadly Tropical Cyclone Mahasen was moving toward and then ...
Satellite sees Tropical Storm Alvin's life end quickly
2013-05-18
The first tropical storm of the Eastern Pacific hurricane season was short-lived. Satellite imagery revealed that Tropical Storm Alvin became a remnant low pressure area 36 hours after it was named.
NASA's GOES Project created an image of Alvin's remnants using infrared data from NOAA's GOES-15 satellite on May 17 at 1200 UTC (8 a.m. EDT). NASA's GOES Project is located at NASA's Goddard Space Flight Center in Greenbelt, Md. Alvin became a named tropical storm on May 15 at 5 p.m. EDT and weakened into a trough (elongated area) of low pressure by 5 a.m. EDT on May 17.
The ...
New formula invented for microscope viewing, substitutes for federally controlled drug
2013-05-18
Researchers at Rutgers, The State University of New Jersey, and City University of New York have invented a proprietary new formulation called VisikolTM that effectively clears organisms to be viewed under microscopes. Visikol can be used in place of chloral hydrate, which is one of the few high-quality clearing solutions currently available but which is tightly regulated by the Drug Enforcement Administration (DEA) due to its use as a narcotic.
Clearing solutions, or clearing agents, are vital for viewing organisms under a microscope. Without them, microscope images ...
Study identifies new approach to improving treatment for MS and other conditions
2013-05-18
(SACRAMENTO, Calif.) — Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.
The findings of the research study, published online today in the journal EMBO Molecular Medicine could have therapeutic applications for MS as well as cerebral palsy and leukodystrophies, all disorders associated with loss of white matter, which is the brain tissue that carries information between nerve cells in the brain ...
More than one-third of Texas women still receive unnecessary breast biopsy surgery
2013-05-18
Many women in Texas who are found to have an abnormality on routine mammogram or discover a lump in one of their breasts end up having an old-fashioned surgical biopsy to find out whether the breast abnormality is malignant. Since 2001, national expert panels have recommended that the first course of action for women with breast lumps or masses should be minimally invasive biopsy.
Minimally invasive biopsies are most commonly done under ultrasonographic or X-ray guidance, with either a fine needle or preferably a "core tissue extraction" needle. They do not require surgery ...
Attacking MRSA with metals from antibacterial clays
2013-05-18
In the race to protect society from infectious microbes, the bugs are outrunning us. The need for new therapeutic agents is acute, given the emergence of novel pathogens as well as old foes bearing heightened antibiotic resistance.
Shelley Haydel, a researcher at Arizona State University's Biodesign Institute has a new approach to developing effective, topical antibacterial agents — one that draws on a naturally occurring substance recognized since antiquity for its medicinal properties: clay.
In research appearing in the journal PLOS ONE, Haydel and her graduate ...
NASA's STEREO detects a CME from the sun
2013-05-18
On 5:24 a.m. EDT on May 17, 2013, the sun erupted with an Earth-directed coronal mass ejection or CME, a solar phenomenon that can send billions of tons of solar particles into space that can reach Earth one to three days later and affect electronic systems in satellites and on the ground. Experimental NASA research models, based on observations from NASA's Solar Terrestrial Relations Observatory, show that the CME left the sun at speeds of around 745 miles per second. The solar material in CMEs cannot pass through the atmosphere to affect humans on Earth.
Not to be confused ...
Front-row seats to climate change
2013-05-18
By day, insects provide the white noise of the South, but the night belongs to the amphibians. In a typical year, the Southern air hangs heavy from the humidity and the sounds of wildlife.
The Southeast, home to more than 140 species of frogs, toads and salamanders, is the center of amphibian biodiversity in our nation. If the ponds and swamps are the auditorium for their symphonic choruses, the scientists of the U.S. Geological Survey's Amphibian Research and Monitoring Initiative, or ARMI, have front-row seats.
Amphibians, which rely on water for part or all ...
For combat veterans suffering from post-traumatic stress disorder, 'fear circuitry' in the brain never rests
2013-05-18
NEW YORK, May 18, 2013. Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or under-react in response to stressful tasks, such as recalling a traumatic event or reacting to a photo of a threatening face. Now, researchers at NYU School of Medicine have explored for the first time what happens in the brains of combat veterans with PTSD in the absence of external triggers.
Their results, published in Neuroscience ...